Integra LifeSciences Holdings Corporation (IART)
NASDAQ: IART · Real-Time Price · USD
16.79
+0.09 (0.54%)
Apr 25, 2025, 4:00 PM EDT - Market closed
IART Revenue
In the year 2024, Integra LifeSciences Holdings had annual revenue of $1.61B with 4.47% growth. Integra LifeSciences Holdings had revenue of $442.65M in the quarter ending December 31, 2024, with 11.49% growth.
Revenue (ttm)
$1.61B
Revenue Growth
+4.47%
P/S Ratio
0.80
Revenue / Employee
$366,362
Employees
4,396
Market Cap
1.30B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.61B | 68.95M | 4.47% |
Dec 31, 2023 | 1.54B | -16.09M | -1.03% |
Dec 31, 2022 | 1.56B | 15.22M | 0.99% |
Dec 31, 2021 | 1.54B | 170.58M | 12.43% |
Dec 31, 2020 | 1.37B | -145.69M | -9.60% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.90B |
IART News
- 8 days ago - Integra LifeSciences to Host First Quarter 2025 Financial Results Conference Call on May 5, 2025 - GlobeNewsWire
- 5 weeks ago - Notice to Long-Term Integra Lifesciences Holdings Corporation (NASDAQ: IART) Shareholders: Grabar Law Investigates Claims on Your Behalf - GlobeNewsWire
- 6 weeks ago - Integra LifeSciences to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference - GlobeNewsWire
- 7 weeks ago - Integra LifeSciences: Light At The End Of The Tunnel, Or Another Oncoming Train? (Rating Upgrade) - Seeking Alpha
- 2 months ago - Integra LifeSciences Holdings Corporation (IART) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Integra LifeSciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides 2025 Financial Guidance - GlobeNewsWire
- 2 months ago - Jan De Witte joins GHO Capital as Operating Partner - GlobeNewsWire
- 2 months ago - Notice To Long-Term Integra Lifesciences Holdings Corporation (NASDAQ: IART) Shareholders: Grabar Law Investigates Claims on Your Behalf - GlobeNewsWire